The goals of the Radiation Biology &Imaging (RBI) Program remain unchanged since the last review of the ACC Core Grant. The RBI program seeks to improve the outcome of patients through the advanced understanding of how ionizing and non-ionizing radiation interacts with cancer and normal tissues. Through the RBI Program, investigators from diverse backgrounds and multiple Departments within the School of Medicine, Veterinary School and the School of Engineering, are brought together to identify the molecular and physiological determinants of radiation and PDT response in tumors. New areas of focus developed in the last two years include the use of nanomaterials to deliver therapeutic and imaging agents to tumors and the use of sophisticated imaging and radiation delivery approaches to better define and evaluate targets and treat tumors with the lowest possible damage to normal tissues. These new efforts have been strengthened with a substantial recruitment effort of new members into the RBI program. The programmatic goals are: 1. to understand the basic molecular mechanisms underlying the cellular response to radiation and to develop molecular targets for manipulating the response of tumors to drugs and ionizing radiation; 2. to develop clinical trials for photodynamic therapy and understand the underlying molecular and physiologic mechanisms that underlie its use; 3. to develop mechanisms to test and validate invasive and non-invasive methods for measuring tumor oxygenation and metabolic status; 4. to study the molecular events in the response to DNA damage by ionizing radiation;and 5. to develop imaging techniques that are related to the delivery and underlying mechanisms of radiation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016520-38
Application #
8593254
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-12-01
Budget End
2014-11-30
Support Year
38
Fiscal Year
2014
Total Cost
$111,965
Indirect Cost
$86,401
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Torre, Eduardo; Dueck, Hannah; Shaffer, Sydney et al. (2018) Rare Cell Detection by Single-Cell RNA Sequencing as Guided by Single-Molecule RNA FISH. Cell Syst 6:171-179.e5
Echevarría-Vargas, Ileabett M; Reyes-Uribe, Patricia I; Guterres, Adam N et al. (2018) Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma. EMBO Mol Med 10:
Romero, Sally A D; Jones, Lee; Bauml, Joshua M et al. (2018) The association between fatigue and pain symptoms and decreased physical activity after cancer. Support Care Cancer 26:3423-3430
Vonderheide, Robert H (2018) The Immune Revolution: A Case for Priming, Not Checkpoint. Cancer Cell 33:563-569
Kall, Stefanie L; Delikatny, Edward J; Lavie, Arnon (2018) Identification of a Unique Inhibitor-Binding Site on Choline Kinase ?. Biochemistry 57:1316-1325
Safo, Sandra E; Li, Shuzhao; Long, Qi (2018) Integrative analysis of transcriptomic and metabolomic data via sparse canonical correlation analysis with incorporation of biological information. Biometrics 74:300-312
Quast, Lauren F; Phillips, Peter C; Li, Yimei et al. (2018) A prospective study of family predictors of health-related quality of life in pediatric brain tumor survivors. Pediatr Blood Cancer 65:e26976
Bart, Stephen M; Cohen, Courtney; Dye, John M et al. (2018) Enhancement of Ebola virus infection by seminal amyloid fibrils. Proc Natl Acad Sci U S A 115:7410-7415
Ecker, Christopher; Guo, Lili; Voicu, Stefana et al. (2018) Differential Reliance on Lipid Metabolism as a Salvage Pathway Underlies Functional Differences of T Cell Subsets in Poor Nutrient Environments. Cell Rep 23:741-755
Alexander, Erica S; Mick, Rosemarie; Nadolski, Gregory J et al. (2018) Combined chemoembolization and thermal ablation for the treatment of metastases to the liver. Abdom Radiol (NY) 43:2859-2867

Showing the most recent 10 out of 1047 publications